Levels of endocannabinoid metabolizing enzymes are not related with BDNF levels in patients with schizophrenia: a case-controlled study
PURPOSE: While the pathogenesis of schizophrenia has yet to be fully clarified, a huge amount of data suggests the involvement of endocannabinoid system and neurotrophic factors in schizophrenia. Nevertheless, only a very limited number of studies have investigated these two systems together. With t...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Mesut Çetin
2019-10-01
|
| Reeks: | Psychiatry and Clinical Psychopharmacology |
| Onderwerpen: | |
| Online toegang: | http://dx.doi.org/10.1080/24750573.2018.1540200 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|